BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27693388)

  • 1. Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions.
    Velaga S; Alter C; Dringenberg U; Thiesler CT; Kuhs S; Olek S; Ukena SN; Franzke A
    Exp Hematol; 2017 Jan; 45():27-35.e1. PubMed ID: 27693388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
    Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
    Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migratory properties of ex vivo expanded regulatory T cells: Influence of all-trans retinoic acid and rapamycin.
    Beermann JL; Thiesler CT; Dringenberg U; Alter C; Kuhs S; Velaga S; Ukena SN; Franzke A
    Transpl Immunol; 2017 Dec; 45():29-34. PubMed ID: 28870639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.
    Alsuliman A; Appel SH; Beers DR; Basar R; Shaim H; Kaur I; Zulovich J; Yvon E; Muftuoglu M; Imahashi N; Kondo K; Liu E; Shpall EJ; Rezvani K
    Cytotherapy; 2016 Oct; 18(10):1312-24. PubMed ID: 27497700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System.
    Marín Morales JM; Münch N; Peter K; Freund D; Oelschlägel U; Hölig K; Böhm T; Flach AC; Keßler J; Bonifacio E; Bornhäuser M; Fuchs A
    Front Immunol; 2019; 10():38. PubMed ID: 30778344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
    Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
    J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of regulatory T cells for clinical applications against graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
    Zhang LF; Xia CQ
    Chin Med J (Engl); 2013 Dec; 126(23):4575-82. PubMed ID: 24286428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
    Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
    Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants.
    Lu SY; Huang XJ; Liu KY; Liu DH; Xu LP
    Clin Transplant; 2012; 26(2):E158-67. PubMed ID: 22507356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage
    Issa F; Milward K; Goto R; Betts G; Wood KJ; Hester J
    Front Immunol; 2019; 10():889. PubMed ID: 31068951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease.
    Velaga S; Ukena SN; Dringenberg U; Alter C; Pardo J; Kershaw O; Franzke A
    PLoS One; 2015; 10(4):e0124927. PubMed ID: 25928296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
    Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
    Front Immunol; 2018; 9():199. PubMed ID: 29467769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD.
    Landwehr-Kenzel S; Müller-Jensen L; Kuehl JS; Abou-El-Enein M; Hoffmann H; Muench S; Kaiser D; Roemhild A; von Bernuth H; Voeller M; Schmueck-Henneresse M; Gruhn B; Stervbo U; Babel N; Volk HD; Reinke P
    Mol Ther; 2022 Jun; 30(6):2298-2314. PubMed ID: 35240319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
    Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.